FDA
Sitagliptin Phosphate
The FDA lists this product in 35 strengths and forms.
Composition
- Active ingredients
- SITAGLIPTIN PHOSPHATE EQ 100MG BASE
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- SITAGLIPTIN PHOSPHATE EQ 50MG BASE · TabletANDA215155-002 · Tentative approval
- SITAGLIPTIN PHOSPHATE EQ 100MG BASE · TabletANDA215155-003 · Tentative approval
- SITAGLIPTIN PHOSPHATE 100MG · TabletANDA211073-003 · Tentative approval
- SITAGLIPTIN PHOSPHATE 25MG · TabletANDA211073-001 · Tentative approval
- SITAGLIPTIN PHOSPHATE 50MG · TabletANDA211073-002 · Tentative approval
- SITAGLIPTIN PHOSPHATE 25MG · TabletANDA202423-001 · Tentative approval
- SITAGLIPTIN PHOSPHATE 50MG · TabletANDA202423-002 · Tentative approval
- SITAGLIPTIN PHOSPHATE 100MG · TabletANDA202423-003 · Tentative approval
- SITAGLIPTIN PHOSPHATE EQ 100MG BASE · TabletANDA202425-003 · Prescription
- SITAGLIPTIN PHOSPHATE EQ 25MG BASE · TabletANDA202425-001 · Prescription
- SITAGLIPTIN PHOSPHATE EQ 50MG BASE · Tablet
At a glance
- Brand name
- Sitagliptin Phosphate
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Ajanta Pharma LTD
- Status
- Tentative approval
- FDA approval
- 24 Feb 2026
- Application
- ANDA214784-003